BPC-157 improves tendon healing in humans.
BPC-157Verdict: Mostly Animal Evidence. Last reviewed Jul 1, 2026. Risk signal: High.
Evidence checks
Claims checked against sources
Peptide Fact Checks reviews one claim at a time. Each public check shows the verdict, evidence grade, risk signal, source trail, and review date so you can separate useful context from confident peptide marketing.
These pages are educational and do not include dosing guidance, protocols, or personalized medical advice.
Reviewed claims
Start here when a peptide claim sounds too clean, too viral, or too certain.
Epitalon extends human lifespan.
EpitalonVerdict: Unsupported. Last reviewed Jul 1, 2026. Risk signal: High.
GHK-Cu improves skin appearance.
GHK-CuVerdict: Limited Evidence. Last reviewed Jul 1, 2026. Risk signal: Medium.
Ipamorelin increases growth hormone release in human volunteers.
IpamorelinVerdict: Supported. Last reviewed Jul 1, 2026. Risk signal: High.
Ipamorelin is claimed to help with injury recovery in humans.
IpamorelinVerdict: Limited Evidence. Last reviewed Jul 1, 2026. Risk signal: Medium.
Melanotan II is a safe tanning peptide.
Melanotan IIVerdict: Risky. Last reviewed Jul 1, 2026. Risk signal: Critical.
MOTS-c improves metabolic health in humans.
MOTS-cVerdict: Mostly Animal Evidence. Last reviewed Jul 1, 2026. Risk signal: High.
Semax improves focus in humans.
SemaxVerdict: Mostly Animal Evidence. Last reviewed Jul 1, 2026. Risk signal: Medium.
Sermorelin stimulates growth hormone release in humans.
SermorelinVerdict: Supported. Last reviewed Jul 1, 2026. Risk signal: Medium.
TB-500 speeds soft tissue recovery in humans.
TB-500Verdict: Overhyped. Last reviewed Jul 1, 2026. Risk signal: High.
Tesamorelin is proven for general weight loss.
TesamorelinVerdict: Misleading. Last reviewed Jul 1, 2026. Risk signal: High.
Tesamorelin reduces excess abdominal fat in adults with HIV-associated lipodystrophy.
TesamorelinVerdict: Supported. Last reviewed Jul 1, 2026. Risk signal: Medium.